Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel and oxaliplatin, work in different
ways to stop tumor cells from dividing so they stop growing or die. Giving more than one drug
may kill more tumor cells.
PURPOSE: This phase I/II trial is studying the side effects and best dose of docetaxel and
oxaliplatin and to see how well they work in treating patients with stage III or stage IV
ovarian epithelial cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)